Endomix logo — Pioneering the Future of Preventive Medicine with Advanced B...

Endomix

Pioneering the Future of Preventive Medicine with Advanced Biotechnology and Clinical Expertise

Founded 2021 Non Equity Assistance Biotechnology, Pharmaceutical

General Information

Company Name Endomix
Founded Year 2021
Industries Biotechnology, Pharmaceutical
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Endomix. To contact Endomix, visit goendomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Endomix compare?

A PDF of Endomix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Endomix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Endomix

Endomix is a biotechnology startup founded in 2021 with the slogan, "Pioneering the Future of Preventive Medicine with Advanced Biotechnology and Clinical Expertise." The company specializes in biotechnology, clinical trials, health diagnostics, and pharmaceuticals, aiming to develop and market technologies that aid in disease prevention. Endomix's offerings include conducting clinical trials and delivering health diagnostic solutions, as well as working on pharmaceutical products that support preventive healthcare. The company received a Non Equity Assistance investment from the TIPS Program on 01 September 2020.

Business keywords: preventive medicine, clinical trials, health diagnostics, pharmaceuticals, disease prevention, medical research, clinical expertise, biotech innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
TIPS Program
01 Sep 2020

Endomix Alternatives & Competitors

View All Alternatives
Endomix vs

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clinical needs...

Series A
Biopharma, Biotechnology
Endomix vs

biosyn Arzneimittel GmbH is a pharmaceutical company promoting immune health in Germany's Pharmaland

30 employees
Biotechnology, Manufacturing
Endomix vs

Finding Innovative Global Health Solutions For Today and Tomorrow Through Clinical Research. # Organ...

110 employees
Biotechnology, Health Care

FAQ About Endomix

Pioneering the Future of Preventive Medicine with Advanced Biotechnology and Clinical Expertise
Endomix was founded in 2021.
Endomix operates in Biotechnology and Pharmaceutical. Its work centres on preventive medicine, clinical trials, health diagnostics and pharmaceuticals.
Endomix has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Endomix include Yuanyin Bio, biosyn Arzneimittel GmbH, Xcene Research, LCM Genect, Shenzhen Regeneration. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Endomix and Yuanyin Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Endomix, https://bouncewatch.com/company/endomix, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes